Title:
CONTROL VALVE
Document Type and Number:
WIPO Patent Application WO/2022/268157
Kind Code:
A1
Abstract:
A control valve (1), comprising a valve body (10) and a valve element (20). The control valve (1) is provided with communication ports (111) located in a side wall portion (11); the valve element (20) comprises a plurality of conduction cavity structures (21); at least some of the conduction cavity structures (21) comprise an inner conduction cavity (211) and a plurality of outer conduction cavities (212); the outer conduction cavities (212) comprise a first outer conduction cavity (EC1) and a second outer conduction cavity (EC2); the communication ports (111) are provided in the height direction of the control valve (1); and by means of the inner conduction cavity (211) and the first outer conduction cavity (EC1), the control valve (1) can conduct two or three communication ports (111) corresponding to the first outer conduction cavity (EC1), and by means of the second outer conduction cavity (EC2), the control valve can conduct two or more communication ports (111) corresponding to the first outer conduction cavity. The control valve can achieve fluid control over a plurality of flow paths.
Inventors:
ZHANG RONGRONG (CN)
Application Number:
PCT/CN2022/100714
Publication Date:
December 29, 2022
Filing Date:
June 23, 2022
Export Citation:
Assignee:
ZHEJIANG SANHUA AUTOMOTIVE COMPONENTS CO LTD (CN)
International Classes:
F16K11/085; F16K25/04; F16K27/06
Foreign References:
| CN110043692A | 2019-07-23 | |||
| CN107940034A | 2018-04-20 | |||
| CN111828687A | 2020-10-27 | |||
| EP2390540A1 | 2011-11-30 | |||
| JPH09280392A | 1997-10-28 |
Attorney, Agent or Firm:
UNITALEN ATTORNEYS AT LAW (CN)
Download PDF:
Previous Patent: DRIVING DEVICE AND CONTROL VALVE
Next Patent: USE OF COMPOUND AS C-MET KINASE INHIBITOR FOR TREATMENT OF NEUROFIBROMATOSIS TYPE I
Next Patent: USE OF COMPOUND AS C-MET KINASE INHIBITOR FOR TREATMENT OF NEUROFIBROMATOSIS TYPE I